Literature DB >> 23966254

Priorities in pediatric epilepsy research: improving children's futures today.

Anne T Berg1, Christine B Baca, Tobias Loddenkemper, Barbara G Vickrey, Dennis Dlugos.   

Abstract

The Priorities in Pediatric Epilepsy Research workshop was held in the spirit of patient-centered and patient-driven mandates for developing best practices in care, particularly for epilepsy beginning under age 3 years. The workshop brought together parents, representatives of voluntary advocacy organizations, physicians, allied health professionals, researchers, and administrators to identify priority areas for pediatric epilepsy care and research including implementation and testing of interventions designed to improve care processes and outcomes. Priorities highlighted were 1) patient outcomes, especially seizure control but also behavioral, academic, and social functioning; 2) early and accurate diagnosis and optimal treatment; 3) role and involvement of parents (communication and shared decision-making); and 4) integration of school and community organizations with epilepsy care delivery. Key factors influencing pediatric epilepsy care included the child's impairments and seizure presentation, parents, providers, the health care system, and community systems. Care was represented as a sequential process from initial onset of seizures to referral for comprehensive evaluation when needed. We considered an alternative model in which comprehensive care would be utilized from onset, proactively, rather than reactively after pharmacoresistance became obvious. Barriers, including limited levels of evidence about many aspects of diagnosis and management, access to care--particularly epilepsy specialty and behavioral health care--and implementation, were identified. Progress hinges on coordinated research efforts that systematically address gaps in knowledge and overcoming barriers to access and implementation. The stakes are considerable, and the potential benefits for reduced burden of refractory epilepsy and lifelong disabilities may be enormous.

Entities:  

Mesh:

Year:  2013        PMID: 23966254      PMCID: PMC3795602          DOI: 10.1212/WNL.0b013e3182a55fb9

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  53 in total

1.  AAN Epilepsy Quality Measures in clinical practice: a survey of neurologists.

Authors:  Vibhangini S Wasade; Marianna Spanaki; Revathi Iyengar; Gregory L Barkley; Lonni Schultz
Journal:  Epilepsy Behav       Date:  2012-07-05       Impact factor: 2.937

2.  Time to pediatric epilepsy surgery is related to disease severity and nonclinical factors.

Authors:  Christine B Baca; Barbara G Vickrey; Stefanie Vassar; Jason S Hauptman; Andrew Dadour; Taemin Oh; Noriko Salamon; Harry V Vinters; Raman Sankar; Gary W Mathern
Journal:  Neurology       Date:  2013-03-06       Impact factor: 9.910

3.  Referral pattern for epilepsy surgery after evidence-based recommendations: a retrospective study.

Authors:  Zulfi Haneef; John Stern; Sandra Dewar; Jerome Engel
Journal:  Neurology       Date:  2010-08-24       Impact factor: 9.910

4.  Patient attitudes about treatments for intractable epilepsy.

Authors:  Kari Swarztrauber; Sandra Dewar; Jerome Engel
Journal:  Epilepsy Behav       Date:  2003-02       Impact factor: 2.937

5.  Racial disparities in the use of surgical treatment for intractable temporal lobe epilepsy.

Authors:  J G Burneo; L Black; R C Knowlton; E Faught; R Morawetz; R I Kuzniecky
Journal:  Neurology       Date:  2005-01-11       Impact factor: 9.910

6.  Incidence of epilepsy in rural Iceland: a population-based study.

Authors:  E Olafsson; W A Hauser; P Ludvigsson; G Gudmundsson
Journal:  Epilepsia       Date:  1996-10       Impact factor: 5.864

7.  The current evaluation and treatment of infantile spasms among members of the Child Neurology Society.

Authors:  John R Mytinger; Sucheta Joshi
Journal:  J Child Neurol       Date:  2012-08-21       Impact factor: 1.987

8.  Diagnoses made in a secondary care "fits, faints, and funny turns" clinic.

Authors:  D Hindley; A Ali; C Robson
Journal:  Arch Dis Child       Date:  2006-03       Impact factor: 3.791

Review 9.  Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society.

Authors:  M T Mackay; S K Weiss; T Adams-Webber; S Ashwal; D Stephens; K Ballaban-Gill; T Z Baram; M Duchowny; D Hirtz; J M Pellock; W D Shields; S Shinnar; E Wyllie; O C Snead
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910

10.  Patient assessment of physician performance of epilepsy quality-of-care measures.

Authors:  Paul Wicks; Nathan B Fountain
Journal:  Neurol Clin Pract       Date:  2012-12
View more
  17 in total

1.  "A journey around the world": Parent narratives of the journey to pediatric resective epilepsy surgery and beyond.

Authors:  Christine B Baca; Huibrie C Pieters; Tomoko J Iwaki; Gary W Mathern; Barbara G Vickrey
Journal:  Epilepsia       Date:  2015-04-20       Impact factor: 5.864

Review 2.  The clinical management of Type 2 Gaucher disease.

Authors:  Karin Weiss; Ashley Gonzalez; Grisel Lopez; Leah Pedoeim; Catherine Groden; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2014-11-14       Impact factor: 4.797

3.  Diagnostic delays in children with early onset epilepsy: impact, reasons, and opportunities to improve care.

Authors:  Anne T Berg; Tobias Loddenkemper; Christine B Baca
Journal:  Epilepsia       Date:  2013-12-06       Impact factor: 5.864

Review 4.  The challenges and innovations for therapy in children with epilepsy.

Authors:  Jo M Wilmshurst; Anne T Berg; Lieven Lagae; Charles R Newton; J Helen Cross
Journal:  Nat Rev Neurol       Date:  2014-04-08       Impact factor: 42.937

5.  The Clinical Research Landscape of Pediatric Drug-Resistant Epilepsy.

Authors:  K Julia Kaal; Magda Aguiar; Mark Harrison; Patrick J McDonald; Judy Illes
Journal:  J Child Neurol       Date:  2020-06-16       Impact factor: 1.987

6.  Thirty Years of Orphan Drug Legislation and the Development of Drugs to Treat Rare Seizure Conditions: A Cross Sectional Analysis.

Authors:  Jan Henje Döring; Anette Lampert; Georg F Hoffmann; Markus Ries
Journal:  PLoS One       Date:  2016-08-24       Impact factor: 3.240

7.  Choice and Trade-offs: Parent Decision Making for Neurotechnologies for Pediatric Drug-Resistant Epilepsy.

Authors:  Viorica Hrincu; Patrick J McDonald; Mary B Connolly; Mark J Harrison; George M Ibrahim; Robert P Naftel; Winston Chiong; Armaghan Alam; Urs Ribary; Judy Illes
Journal:  J Child Neurol       Date:  2021-06-02       Impact factor: 1.987

8.  Development and Evaluation of the CASTLE Trial Online Sleep Intervention for Parents of Children with Epilepsy.

Authors:  Luci Wiggs; Georgia Cook; Harriet Hiscock; Deb K Pal; Paul Gringras
Journal:  Front Psychol       Date:  2021-07-02

Review 9.  Neuroactive peptides as putative mediators of antiepileptic ketogenic diets.

Authors:  Carmela Giordano; Maddalena Marchiò; Elena Timofeeva; Giuseppe Biagini
Journal:  Front Neurol       Date:  2014-04-29       Impact factor: 4.003

10.  Ten Years after the International Committee of Medical Journal Editors' Clinical Trial Registration Initiative, One Quarter of Phase 3 Pediatric Epilepsy Clinical Trials Still Remain Unpublished: A Cross Sectional Analysis.

Authors:  Anette Lampert; Georg F Hoffmann; Markus Ries
Journal:  PLoS One       Date:  2016-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.